Safety of four SGLT2 inhibitors in three chronic diseases: A meta-analysis of large randomized trials of SGLT2 inhibitors.

MLA

Mei Qiu, et al. “Safety of Four SGLT2 Inhibitors in Three Chronic Diseases: A Meta-Analysis of Large Randomized Trials of SGLT2 Inhibitors.” Diabetes & Vascular Disease Research, vol. 18, no. 2, Mar. 2021, pp. 1–3. EBSCOhost, https://doi.org/10.1177/14791641211011016.

APA

Mei Qiu, Liang-Liang Ding, Miao Zhang, & Hai-Rong Zhou. (2021). Safety of four SGLT2 inhibitors in three chronic diseases: A meta-analysis of large randomized trials of SGLT2 inhibitors. Diabetes & Vascular Disease Research, 18(2), 1–3. https://doi.org/10.1177/14791641211011016

Chicago

Mei Qiu, Liang-Liang Ding, Miao Zhang, and Hai-Rong Zhou. 2021. “Safety of Four SGLT2 Inhibitors in Three Chronic Diseases: A Meta-Analysis of Large Randomized Trials of SGLT2 Inhibitors.” Diabetes & Vascular Disease Research 18 (2): 1–3. doi:10.1177/14791641211011016.